

Publisher: Bentham Science Publishers
E-ISSN: 2212-3989|17|3|185-191
ISSN: 1871-5265
Source: Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol.17, Iss.3, 2017-09, pp. : 185-191
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content










Synthesis and Evaluation of 99mTc Chelate-conjugated Bevacizumab
Current Radiopharmaceuticals, Vol. 6, Iss. 1, 2013-03 ,pp. :